<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="research-article" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molecules</journal-id>
      <journal-title>Molecules</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molecules</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molecules</abbrev-journal-title>
      <issn pub-type="epub">1420-3049</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/molecules21101353</article-id>
      <article-id pub-id-type="publisher-id">molecules-21-01353</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Tetrandrine Induces Apoptosis of Human Nasopharyngeal Carcinoma NPC-TW 076 Cells through Reactive Oxygen Species Accompanied by an Endoplasmic Reticulum Stress Signaling Pathway</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Ya-Jing</given-names>
          </name>
          <xref rid="af1-molecules-21-01353" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Peng</surname>
            <given-names>Shu-Fen</given-names>
          </name>
          <xref rid="af1-molecules-21-01353" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Meng-Liang</given-names>
          </name>
          <xref rid="af2-molecules-21-01353" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuo</surname>
            <given-names>Chao-Lin</given-names>
          </name>
          <xref rid="af3-molecules-21-01353" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>Kung-Wen</given-names>
          </name>
          <xref rid="af4-molecules-21-01353" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liao</surname>
            <given-names>Ching-Lung</given-names>
          </name>
          <xref rid="af4-molecules-21-01353" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>Yi-Shih</given-names>
          </name>
          <xref rid="af5-molecules-21-01353" ref-type="aff">5</xref>
          <xref rid="af6-molecules-21-01353" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chueh</surname>
            <given-names>Fu-Shin</given-names>
          </name>
          <xref rid="af7-molecules-21-01353" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Kuo-Ching</given-names>
          </name>
          <xref rid="af2-molecules-21-01353" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>Fu-Shun</given-names>
          </name>
          <xref rid="af8-molecules-21-01353" ref-type="aff">8</xref>
          <xref rid="c1-molecules-21-01353" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Jing-Gung</given-names>
          </name>
          <xref rid="af1-molecules-21-01353" ref-type="aff">1</xref>
          <xref rid="af9-molecules-21-01353" ref-type="aff">9</xref>
          <xref rid="c1-molecules-21-01353" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>McPhee</surname>
            <given-names>Derek J.</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-molecules-21-01353"><label>1</label>Department of Biological Science and Technology, China Medical University, Taichung 40402, Taiwan; <email>cathy263938@gmail.com</email> (Y.-J.L.); <email>sfpeng@mail.cmu.edu.tw</email> (S.-F.P.)</aff>
      <aff id="af2-molecules-21-01353"><label>2</label>Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 40402, Taiwan; <email>mllinsally@yahoo.com.tw</email> (M.-L.L.); <email>kchliu@mail.cmu.edu.tw</email> (K.C.L.)</aff>
      <aff id="af3-molecules-21-01353"><label>3</label>Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 40402, Taiwan; <email>clkuo@mail.cmu.edu.tw</email></aff>
      <aff id="af4-molecules-21-01353"><label>4</label>College of Chinese Medicine, School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung 40402, Taiwan; <email>prorna@mail.cmu.edu.tw</email> (K.-W.L.); <email>qbking@ms29.hinet.net</email> (C.-L.L.)</aff>
      <aff id="af5-molecules-21-01353"><label>5</label>Department of Chinese Medicine, E-Da Hospital, Kaohsiung 82445, Taiwan; <email>m2367591@ms25.hinet.net</email></aff>
      <aff id="af6-molecules-21-01353"><label>6</label>School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung 82445, Taiwan</aff>
      <aff id="af7-molecules-21-01353"><label>7</label>Department of Health and Nutrition Biotechnology, Asia University, Wufeng, Taichung 41354, Taiwan; <email>fushin@asia.edu.tw</email></aff>
      <aff id="af8-molecules-21-01353"><label>8</label>School of Dentistry, China Medical University, Taichung 40402, Taiwan</aff>
      <aff id="af9-molecules-21-01353"><label>9</label>Department of Biotechnology, Asia University, Wufeng, Taichung 41354, Taiwan</aff>
      <author-notes>
        <corresp id="c1-molecules-21-01353"><label>*</label>Correspondence: <email>fsyu@mail.cmu.edu.tw</email> (F.-S.Y.); <email>jgchung@mail.cmu.edu.tw</email> (J.-G.C.); Tel.: +886-4-2205-3366 (ext. 2310) (F.-S.Y.); +886-4-2205-3366 (ext. 8000) (J.-G.C.); Fax: +886-4-2201-4043 (F.-S.Y.); +886-4-2205-3764 (J.-G.C.)</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>10</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection"><month>10</month>
        <year>2016</year>
      </pub-date>
      <volume>21</volume>
      <issue>10</issue>
      <elocation-id>1353</elocation-id>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>08</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>10</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>Nasopharyngeal carcinoma (NPC) is an epithelial malignancy of the head and neck and the incidence is higher in Southeast Asia. Tetrandrine (TET) is a bisbenzylisoquinoline alkaloid, a natural product, and exhibits biological activities including action against many human cancer cell lines. However, the molecular mechanism of TET-induced cell apoptosis in human NPC cells is still unclear. In the present study, we investigated TET-induced apoptotic cell death and associated possible signal pathways on human nasopharyngeal carcinoma NPC-TW 076 cells in vitro. Phase contrast microscopy was used to examine cell morphology and DAPI staining was used to examine chromatin condensation. Flow cytometry assay was used to measure total viable cells, cell cycle and sub-G<sub>1</sub> phase distribution, reactive oxygen species (ROS), Ca<sup>2+</sup>, and mitochondria membrane potential (&#x394;<italic>&#x3A8;m</italic>) in NPC-TW 076 cells. Results indicate that TET induced cell death through the cell morphological changes, caused G<sub>0</sub>/G<sub>1</sub> phase arrest, increased ROS and Ca<sup>2+</sup> production, and finally caused apoptotic cell death in NPC-TW 076 cells. There was no influence on the level of &#x394;<italic>&#x3A8;m</italic> after TET treatment. Western blotting indicated that TET increased endoplasmic reticulum (ER) stress associated protein expression such as GADD153, GRP78, ATF-6&#x3B1; and ATF-6 &#x3B2;which indicated that TET induced cell death through ER stress. ER stress is a potential target in cancer treatment, so the ability of TET to induce ER stress response and to activate programming cell death in NPC-TW 076 cells make this molecule become a promising anticancer agent.</p>
      </abstract>
      <kwd-group>
        <kwd>tetrandrine (TET)</kwd>
        <kwd>endoplasmic reticulum (ER) stress</kwd>
        <kwd>reactive oxygen species (ROS)</kwd>
        <kwd>apoptosis</kwd>
        <kwd>NPC-TW 076 cells</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-molecules-21-01353" sec-type="intro">
      <title>1. Introduction</title>
      <p>Nasopharyngeal carcinoma (NPC) is an endemic disease particularly in Southeast Asia and Southern China [<xref ref-type="bibr" rid="B1-molecules-21-01353">1</xref>,<xref ref-type="bibr" rid="B2-molecules-21-01353">2</xref>]. In Taiwan, NPC is the fifteenth most common cancer and the mortality rate was 2.2 people per 100,000 population per year from NPC based on the 2016 report from the Department of Health [<xref ref-type="bibr" rid="B3-molecules-21-01353">3</xref>]. Epidemic studies have shown that genetic, environmental and viral factors are associated with NPC development [<xref ref-type="bibr" rid="B4-molecules-21-01353">4</xref>,<xref ref-type="bibr" rid="B5-molecules-21-01353">5</xref>,<xref ref-type="bibr" rid="B6-molecules-21-01353">6</xref>]. NPC is known to be sensitive to radiotherapy, thus, early non-metastatic patients with NPC used radiotherapy for treatment [<xref ref-type="bibr" rid="B7-molecules-21-01353">7</xref>]. Currently, the treatment of NPC usually involves the combined use of radiotherapy and systemic chemotherapy [<xref ref-type="bibr" rid="B8-molecules-21-01353">8</xref>], however, it still has side effects. Abundant evidences have demonstrated that new compounds from natural products, including Chinese herbal medicines, can reduce the side effects while treating NPC patients. Induced cancer cell apoptosis is recognized to be one of the best strategies for anticancer drug development.</p>
      <p>Apoptosis, a programmed cell death, can be triggered by extrinsic (death receptor) pathway or intrinsic (mitochondrial dependent) pathway, or both [<xref ref-type="bibr" rid="B9-molecules-21-01353">9</xref>]. The extrinsic pathway involves Fas (one of the tumor necrosis factor family of apoptosis induction receptors) and Fas-L followed by recruiting and activating procaspase-8 [<xref ref-type="bibr" rid="B10-molecules-21-01353">10</xref>] and activated caspase-8 initiates downstream caspase-3 and triggers cell apoptosis. The intrinsic pathway involves the alteration of mitochondrial membrane potentials, followed by the release of cytochrome c from mitochondria into the cytosol and activates caspase-9 and cspase-3 for cell apoptosis. Thus, the mitochondria control mechanisms underlying apoptosis lead to the release of protein effectors such as cytochrome c, AIF and Endo G [<xref ref-type="bibr" rid="B11-molecules-21-01353">11</xref>,<xref ref-type="bibr" rid="B12-molecules-21-01353">12</xref>,<xref ref-type="bibr" rid="B13-molecules-21-01353">13</xref>,<xref ref-type="bibr" rid="B14-molecules-21-01353">14</xref>]. </p>
      <p>Tetrandrine (TET) is a bisbenzylisoquinoline alkaloid, a natural product, and is purified from the root of <italic>Stephania tetrandra</italic> (Hang fang ji) of the Menispermaceae and it has been shown to exhibit numerous biological activities such as antihypertensive and antiarrhythmic functions [<xref ref-type="bibr" rid="B15-molecules-21-01353">15</xref>], immunomodulation [<xref ref-type="bibr" rid="B16-molecules-21-01353">16</xref>], anticancer effects against several cancers [<xref ref-type="bibr" rid="B17-molecules-21-01353">17</xref>,<xref ref-type="bibr" rid="B18-molecules-21-01353">18</xref>,<xref ref-type="bibr" rid="B19-molecules-21-01353">19</xref>,<xref ref-type="bibr" rid="B20-molecules-21-01353">20</xref>], and increased animal survival time and survival rate in vivo [<xref ref-type="bibr" rid="B21-molecules-21-01353">21</xref>,<xref ref-type="bibr" rid="B22-molecules-21-01353">22</xref>,<xref ref-type="bibr" rid="B23-molecules-21-01353">23</xref>,<xref ref-type="bibr" rid="B24-molecules-21-01353">24</xref>]. Furthermore, in human drug-resistant esophageal squamous carcinoma cells, TET enhances the cytotoxicity of cisplatin via inhibition of multidrug resistance-associated protein 1 [<xref ref-type="bibr" rid="B25-molecules-21-01353">25</xref>]. TET suppresses cancer angiogenesis and metastasis in 4T1 breast tumor-bearing BALB/c mice [<xref ref-type="bibr" rid="B26-molecules-21-01353">26</xref>]. TET exhibited strong inhibitory effect on human prostate cancer cell proliferation, migration, and invasion in vitro [<xref ref-type="bibr" rid="B27-molecules-21-01353">27</xref>]. However, TET revealed a potential therapeutic effect on nasopharyngeal cancer and was able to sensitize the human nasopharyngeal carcinoma CNE cells under radiation therapy [<xref ref-type="bibr" rid="B28-molecules-21-01353">28</xref>].</p>
      <p>Anti-cancer effects of TET have been reported in various cancer cell lines in vitro or in vivo. However, few reports have described about the anti-cancer effect of TET on human nasopharyngeal carcinoma cells. In this study, we investigated the effects of TET and the molecular mechanism of TET on the induction of apoptosis in human nasopharyngeal carcinoma NPC-TW 076 cells. Our results suggest that TET-induced cell apoptosis through endoplasmic reticulum stress signaling pathway in human nasopharyngeal carcinoma NPC-TW 076 cells.</p>
    </sec>
    <sec id="sec2-molecules-21-01353" sec-type="results">
      <title>2. Results</title>
      <sec id="sec2dot1-molecules-21-01353">
        <title>2.1. TET Induced Cell Morphological Changes and Decreased the Total Viable Cell Number in NPC-TW 076 Cells</title>
        <p>The NPC-TW 076 cells were treated with different concentrations of TET for 48 h. As shown in <xref ref-type="fig" rid="molecules-21-01353-f001">Figure 1</xref>A,B, TET treatment significantly reduced total viable cell number (<xref ref-type="fig" rid="molecules-21-01353-f001">Figure 1</xref>A) at 48 h treatment with an IC<sub>50</sub> of 8.2 &#x3BC;M (<xref ref-type="fig" rid="molecules-21-01353-f001">Figure 1</xref>B). TET treatment (4&#x2013;10 &#x3BC;M) obviously induced cell morphological changes compared to the control (<xref ref-type="fig" rid="molecules-21-01353-f001">Figure 1</xref>C).</p>
      </sec>
      <sec id="sec2dot2-molecules-21-01353">
        <title>2.2. TET Induced Nuclear Condensation in NPC-TW 076 Cells</title>
        <p>NPC-TW 076 cells were treated with TET (0&#x2013;10 &#x3BC;M) for 48 h and then were stained with DAPI, photographed by fluorescence microscopy and the results are shown in <xref ref-type="fig" rid="molecules-21-01353-f002">Figure 2</xref>. <xref ref-type="fig" rid="molecules-21-01353-f002">Figure 2</xref>A,B indicated that higher TET concentration led to brighter DAPI fluorescence of NPC-TW 076 cells after 48 h treatment when compared to control. Furthermore, the higher TET concentration results in lower cancer cell number (<xref ref-type="fig" rid="molecules-21-01353-f002">Figure 2</xref>A). The bright fluorescence means that cells have nicked DNA and nuclear chromatin condensation.</p>
      </sec>
      <sec id="sec2dot3-molecules-21-01353">
        <title>2.3. TET Induced G<sub>0</sub>/G<sub>1</sub> Phase Arrest and Sub-G<sub>1</sub> Phase in NPC-TW 076 Cells</title>
        <p>In order to understand whether TET decreased cell number via cell cycle arrest and/or induced apoptotic cell death, NPC-TW 076 cells were treated with 0, 4, 6, 8 and 10 &#x3BC;M of TET for 48 h. Cells were collected to analyze cell cycle distribution and sub-G<sub>1</sub> phase and the results are shown in <xref ref-type="fig" rid="molecules-21-01353-f003">Figure 3</xref>. The results indicated that TET induced G<sub>0</sub>/G<sub>1</sub> phase arrest (<xref ref-type="fig" rid="molecules-21-01353-f003">Figure 3</xref>A) and these effects are dose-dependent (<xref ref-type="fig" rid="molecules-21-01353-f003">Figure 3</xref>B). Results also show that TET induce sub-G<sub>1</sub> phase (apoptosis) in NPC-TW 076 cells (<xref ref-type="fig" rid="molecules-21-01353-f003">Figure 3</xref>A,B).</p>
      </sec>
      <sec id="sec2dot4-molecules-21-01353">
        <title>2.4. TET Induced Reactive Oxygen Species (ROS) and Ca<sup>2+</sup> Productions but no Change in the Levels of Mitochondrial Membrane Potential (&#x394;&#x3A8;m) in NPC-TW 076 Cells</title>
        <p>In order to investigate whether the production of ROS and Ca<sup>2+</sup> or dysfunction of mitochondrial involved TET induced cell death in NPC-TW 076 cells, cells were treated with 8 &#x3BC;M of TET for various time periods and the results are shown in <xref ref-type="fig" rid="molecules-21-01353-f004">Figure 4</xref>. As shown in <xref ref-type="fig" rid="molecules-21-01353-f004">Figure 4</xref>A, TET increased ROS production during 6&#x2013;12 h treatment. Cells pretreated with NAC (scavenger of ROS) and then treated with TET resulted in decreased ROS production (<xref ref-type="fig" rid="molecules-21-01353-f004">Figure 4</xref>B) but increased total viable cells when compared to TET treated only (<xref ref-type="fig" rid="molecules-21-01353-f004">Figure 4</xref>C). TET increased Ca<sup>2+</sup> production during 6&#x2013;48 h treatment (<xref ref-type="fig" rid="molecules-21-01353-f004">Figure 4</xref>D), however, NAC or 4PBA (ER stress blocker) pretreatment led to decreased Ca<sup>2+</sup> production when compared to TET treatment only (<xref ref-type="fig" rid="molecules-21-01353-f004">Figure 4</xref>E). However, TET did not obviously affect the levels of mitochondrial membrane potential (<italic>&#x394;&#x3A8;m</italic>) from 6 h up to 48 h treatment (<xref ref-type="fig" rid="molecules-21-01353-f004">Figure 4</xref>F). These results indicated that ROS and Ca<sup>2+</sup> are involved in TET induced cell apoptosis in NPC-TW 076 cells in vitro.</p>
      </sec>
      <sec id="sec2dot5-molecules-21-01353">
        <title>2.5. TET Altered Apoptosis Associated Protein Expression in NPC-TW 076 Cells</title>
        <p>Western blotting analysis was used to investigate the effects of apoptotic cell death associated protein expression induced by TET in NPC-TW 076 cells. NPC-TW 076 cells were treated with TET for various time periods and protein expressions were measured and results are shown in <xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>. The results showed that TET significantly increased the expression of FasL, Fas, cleaved caspase-8, caspase-7 (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>A), Bax, Bcl-xL, and Bcl-2 (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>B), however, cyto c, AIF and Endo G (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>C) were decreased. Based on these observations, TET induced cell apoptosis was not involved in mitochondria dysfunction. TET increased calpain 1, calpain 2, caspase-12, IRE-1&#x3B1;, IRE-1&#x3B2; (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>D), GADD153, GRP78, ATF-6&#x3B1;, and ATF-6&#x3B2; (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>E) that is associated with ER stress, thus, TET induced cell apoptosis may be through ER stress. Cells were pretreated with NAC and then treated with TET and the results show decreased GRP78, Caspase-12, ATF-6&#x3B1;, calpain 1 protein expressions that are associated with ER stress (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>F). Catalase, GST, and SOD provide major antioxidant defenses against ROS. Furthermore, exposures of NPC-TW 076 cells to TET treatment caused decreased GST expression after 12 h and increased SOD (Cu/Zn) expression from 9 to 12 h (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>G). As shown in <xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>H, TET induced ER stress because we found that the expression of CHOP protein increase after 12 h treatment course and the expression of eIFG2&#x3B1; decrease after 6 to 48 h treatment. Other apoptotic proteins also revealed that TET induced apoptosis because of the increase of cleaved PARP protein from 6 to 48 h TET treatment and the increase of caspase 3 at 12 h treatment course.</p>
      </sec>
      <sec id="sec2dot6-molecules-21-01353">
        <title>2.6. TET Altered the Translocation of Apoptotic Associated Proteins in NPC-TW 076 Cells</title>
        <p>For further investigating the altering translocation of apoptosis associated protein such as GADD153 and GRP78 in NPC-TW 076 cells induced by TET, confocal laser microscopy was performed. Cells were treated with or without 8 &#x3BC;M of TET for 24 h, followed by staining with anti-GADD153 and GRP78 and then were photographed by confocal laser microscopic systems and the results are shown in <xref ref-type="fig" rid="molecules-21-01353-f006">Figure 6</xref>. These results indicated that TET treatment can increase the nuclear translocations of GADD153 (<xref ref-type="fig" rid="molecules-21-01353-f006">Figure 6</xref>A) and GRP78 (<xref ref-type="fig" rid="molecules-21-01353-f006">Figure 6</xref>B). Both proteins were translocated into nuclei when compare to untreated group.</p>
      </sec>
    </sec>
    <sec id="sec3-molecules-21-01353" sec-type="discussion">
      <title>3. Discussion</title>
      <p>More than 90% of NPCs are undifferentiated carcinomas, thus, they show relative sensitivity to chemotherapy. These therapies have shown relatively high efficacy, however, and the survival of patients with late stage of NPC has not significantly improved [<xref ref-type="bibr" rid="B29-molecules-21-01353">29</xref>,<xref ref-type="bibr" rid="B30-molecules-21-01353">30</xref>,<xref ref-type="bibr" rid="B31-molecules-21-01353">31</xref>]. Therefore, the identification of novel drugs from natural products is one of the strategies for improving the treatment options of patients with advanced NPC. Currently, although abundant evidence has shown that TET induces cell death in many human cancer cell lines, little is known about its effect on nasopharyngeal carcinoma cells. TET displays multiple anti-tumor activities including the inhibition of proliferation, angiogenesis, migration, and invasion, the induction of apoptosis, the reversal of multidrug resistance, and sensitization of radiation effects [<xref ref-type="bibr" rid="B28-molecules-21-01353">28</xref>]. TET induces apoptosis in nasopharyngeal carcinoma CNE cells by down-regulating Bcl-2 mRNA and up-regulating Bax mRNA expression. TET also sensitizes CNE cells to irradiation-induced cytotoxicity and might abrogate radiation-induced G<sub>2</sub> phase arrest [<xref ref-type="bibr" rid="B32-molecules-21-01353">32</xref>]. However, there is no report to show the effects of TET on human nasopharyngeal carcinoma NPC-TW 076 cells. Herein, we investigate the cytotoxic effects of TET and associated possible signal pathways on human nasopharyngeal carcinoma NPC-TW 076 cells in vitro. Results indicated that TET reduced cell number via decreased cell viability and cell morphological changes (<xref ref-type="fig" rid="molecules-21-01353-f001">Figure 1</xref>A,C), induced G<sub>0</sub>/G<sub>1</sub> phase arrest and sub-G<sub>1</sub> phase (apoptotic cell death) (<xref ref-type="fig" rid="molecules-21-01353-f002">Figure 2</xref>A,B), and induced nuclear chromatin condensation (<xref ref-type="fig" rid="molecules-21-01353-f003">Figure 3</xref>A,B). Furthermore, flow cytometric assays showed that TET increased ROS and Ca<sup>2+</sup> levels but did not significantly affect the levels of <italic>&#x394;&#x3A8;m</italic> (<xref ref-type="fig" rid="molecules-21-01353-f004">Figure 4</xref>). Western blotting indicated that TET significantly increased the expression of calpain 1, calpain 2, caspase-12, IRE-1&#x3B1;, IRE-1&#x3B2; (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>D), GADD153, GRP78, ATF-6&#x3B1;, and ATF-6&#x3B2; (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>E) that is associated with ER stress. Thus, TET induced cell apoptosis may be through ER stress.</p>
      <p>The anticancer properties of drugs sometimes come from the ability to induce cell cycle arrest, thus we determined the effects of TET on the cell cycle arrest. Flow cytometric analysis exhibited an increased accumulation of cells in the G<sub>0</sub>/G<sub>1</sub> phase accompany with sub-G<sub>1</sub> phase present in TET-treated group when compared to control group (<xref ref-type="fig" rid="molecules-21-01353-f003">Figure 3</xref>A,B). Further, we also used DAPI staining to show TET induces chromatin condensation which is also a characteristic of cell apoptosis. The mechanism of TET-mediated regulation of apoptotic and cell cycle-related genes require further investigation.</p>
      <p>In order to further investigate the possible apoptotic signaling pathways induced by TET in NPC-TW 076 cells, cells were treated with TET and the production of ROS and Ca<sup>2+</sup> were measured. We found that TET significantly increased the production of both ROS and Ca<sup>2+</sup> and those effects are time-dependent. The balance between the accumulation of ROS and the activity of antioxidant system can partially regulate cell cycle progression, thus, drugs with the ability to interfere this balance can control the progression of cell proliferation [<xref ref-type="bibr" rid="B31-molecules-21-01353">31</xref>]. The breakdown in oxidative phosphorylation and subsequently a decrease in ATP and loss of <italic>&#x3A8;m</italic> has been recognized to be one of the earliest events in apoptosis [<xref ref-type="bibr" rid="B12-molecules-21-01353">12</xref>]. Reactive oxygen species (ROS) (by-products of normal cellular oxidative processes) act by regulating the processes involved in the initiation of apoptotic signaling. It has been shown that an increase in ROS generation in the mitochondria can induce cytochrome c release from mitochondria to the cytosol to mediate the apoptotic process [<xref ref-type="bibr" rid="B33-molecules-21-01353">33</xref>]. The next experiment was used NAC (a ROS scavenger) to pretreat NPC-TW 076 cells before the TET treatment. We found that the NAC pretreatment can reduce the ROS production and had higher cell viability than TET treatment alone (<xref ref-type="fig" rid="molecules-21-01353-f004">Figure 4</xref>B,C). The overproduction of ROS can cause severe cellular damage and initiate the cancer development [<xref ref-type="bibr" rid="B34-molecules-21-01353">34</xref>]. </p>
      <p>The endoplasmic reticulum (ER) is also a Ca<sup>2+</sup> storage compartment of cells, and when suffering from ER stress, Ca<sup>2+</sup> ions will be released into the cytoplasm followed by activation of numerous kinases and proteases [<xref ref-type="bibr" rid="B35-molecules-21-01353">35</xref>]. ER stress has been recognized to be triggered by the accumulation of misfolded and/or unfolded proteins in the ER lumen and it leads to disruption of ER homeostasis. ER stress has been reported to be involved in specific transcriptional and translational responses that are largely controlled by three ER resident sensor proteins: inositol-requiring enzyme 1 (IRE1), ATF6, and PRKR-like endoplasmic reticulum kinase (PERK) [<xref ref-type="bibr" rid="B36-molecules-21-01353">36</xref>,<xref ref-type="bibr" rid="B37-molecules-21-01353">37</xref>,<xref ref-type="bibr" rid="B38-molecules-21-01353">38</xref>]. Furthermore, ER stress has also been recognized to be a cellular response to anticancer treatment [<xref ref-type="bibr" rid="B39-molecules-21-01353">39</xref>,<xref ref-type="bibr" rid="B40-molecules-21-01353">40</xref>]. Our western blotting results indicated that TET significantly increased the expression of activating transcription factor 6&#x3B1; (ATF-6&#x3B1;), activating transcription factor 6&#x3B2; (ATF-6&#x3B2;), glucose-regulated protein 78 kDa (GRP78), GADD153 (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>E), calpain 1 and 2, and caspase-12 (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>D) that were documented to be the hall markers of ER stress. GRP78 and GADD153 proteins were increased in NPC-TW 076 cells after exposed to TET (<xref ref-type="fig" rid="molecules-21-01353-f005">Figure 5</xref>E). In addition to being a sensor of ER stress, GRP78 has been shown to serve as a gatekeeper to the activation of the ER stress transducers [<xref ref-type="bibr" rid="B41-molecules-21-01353">41</xref>,<xref ref-type="bibr" rid="B42-molecules-21-01353">42</xref>]. GADD153 is crucial for switching to pro-apoptotic signaling [<xref ref-type="bibr" rid="B43-molecules-21-01353">43</xref>]. We also used confocal laser microscopy to confirm that TET promoted the translocation of GADD153 and GRP78 from cytoplasm to nuclei (<xref ref-type="fig" rid="molecules-21-01353-f006">Figure 6</xref>A,B). Therefore, we suggest that TET induces apoptotic cell death in NPC-TW 076 cells through the ER stress pathway. Our results also are consistent with the mechanism of the TET bromide derivative that induced ER stress and apoptosis on human non-small cell lung cancer cells [<xref ref-type="bibr" rid="B44-molecules-21-01353">44</xref>].</p>
      <p>In conclusion, our results provide strong evidence to support the role of ER stress in mediating the apoptotic effect of TET on NPC-TW 076 cells in vitro. Treatment with TET induces expression of a number of signature ER stress markers. Overall, the possible pathways for TET induced cell apoptosis in NPC-TW 076 cells are summarized in <xref ref-type="fig" rid="molecules-21-01353-f007">Figure 7</xref>. These findings indicate the therapeutic potential of TET in treating human nasopharyngeal carcinoma in the future.</p>
    </sec>
    <sec id="sec4-molecules-21-01353">
      <title>4. Experimental Section</title>
      <sec id="sec4dot1-molecules-21-01353">
        <title>4.1. Chemicals and Reagents</title>
        <p>Tetrandrine (TET) of 99% purity, 4&#x2032;,6-diamidino-2-phenylindole (DAPI), <italic>N</italic>-acetyl-<sc>l-</sc>cysteine (NAC), 4-phenylbutyrate (4PBA), dimethyl sulfoxide (DMSO), propidium iodide (PI) and Trypsin-EDTA were obtained from Sigma Chemical Co. (St. Louis, MO, USA). RPMI1640 medium, fetal bovine serum (FBS), <sc>l</sc>-glutamine and penicillin-streptomycin were purchased from GIBCO<sup>&#xAE;</sup>/Invitrogen Life Technologies (Carlsbad, CA, USA). Primary antibody against caspase-7, -8 and -12, calpain 1, calpain 2, Fas, Fas-L, AIF, Endo G, XIAP, GADD153, GRP78, Catalase and GST were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA) and cytochrome c, Bid, Bax, Bcl-2, Bcl-xL, IRE-1&#x3B1;, IRE-1&#x3B2;, ATF-6&#x3B1;, ATF-6&#x3B2;, SOD and peroxidase conjugated secondary antibodies were purchased from Cell Signaling Technology, Inc. (Beverly, MA, USA). TET was dissolved in DMSO. Cell culture grade DMSO as used for vehicle at 0.1%.</p>
      </sec>
      <sec id="sec4dot2-molecules-21-01353">
        <title>4.2. Cell Culture</title>
        <p>The human nasopharyngeal carcinoma NPC-TW 076 cells line was purchased from the Food Industry Research and Development Institute (Hsinchu, Taiwan). NPC-TW 076 cells were grown in RPMI1640 medium supplemented with 10% heat inactivated fetal bovine serum (FBS) and antibiotics (100 unit/mL penicillin, 100 &#x3BC;g/mL streptomycin, and 2 mM glutamine). The cell lines were cultured in an incubator at 37 &#xB0;C in a humidified atmosphere containing 5% carbon dioxide (CO<sub>2</sub>) [<xref ref-type="bibr" rid="B45-molecules-21-01353">45</xref>]. </p>
      </sec>
      <sec id="sec4dot3-molecules-21-01353">
        <title>4.3. Cell Viability and Morphology Examinations</title>
        <p>Cell viability was measured using a flow cytometric assay. NPC-TW 076 cells were maintained at a concentration of 1 &#xD7; 10<sup>5</sup> cells/well in 12-well plates with RPMI1640 medium for 24 h. Cells were treated with TET at a concentration range of 0&#x2013;9 &#x3BC;M for 48 h. After incubation, for total cell viability, cells were collected, counted and stained with PI (5 &#x3BC;g/mL) and then were measured by FACSCalibur flow cytometry (BD Biosciences, San Jose, CA, USA) and cells treated with TET at a concentration range of 0&#x2013;10 &#x3BC;M for 48 h were examined for morphological changes and photographed under phase contrast microscopy at 200&#xD7; as previously described [<xref ref-type="bibr" rid="B46-molecules-21-01353">46</xref>]. </p>
      </sec>
      <sec id="sec4dot4-molecules-21-01353">
        <title>4.4. Chromatin Condensation Stained with DAPI </title>
        <p>NPC-TW 076 cells (1 &#xD7; 10<sup>5</sup> cells/well) were placed in 12-well plates and cells were treated with TET at final concentrations (0, 4, 6, 8 and 10 &#x3BC;M) for 48 h. Cells were fixed in 3% paraformaldehyde in PBS for 20 min at room temperature, followed by washing with PBS. Cells were then stained with DAPI solution (2 &#x3BC;g/mL) at room temperature in the dark. The chromatin condensation (nuclear morphology) was examined and photographed using a fluorescence microscope as described previously [<xref ref-type="bibr" rid="B47-molecules-21-01353">47</xref>].</p>
      </sec>
      <sec id="sec4dot5-molecules-21-01353">
        <title>4.5. Cell Cycle and Sub-G<sub>1</sub> Phase (Apoptosis) Assays </title>
        <p>The percentage of cell cycle distribution and sub-G<sub>1</sub> hypoploid cells were measured by flow cytometry as previously described [<xref ref-type="bibr" rid="B44-molecules-21-01353">44</xref>]. Briefly, NPC-TW 076 cells (1 &#xD7; 10<sup>5</sup> cells/well) were maintained in 12-well plates and cells were treated with TET at final concentrations (0, 4, 6, 8 and 10 &#x3BC;M) for 48 h. Cells were collected, washed, fixed in 70% ethanol for 30 min, and incubated with a solution containing 50 mg/mL PI and 50 &#x3BC;g/mL RNase A in the dark at 37 &#xB0;C. And then cells were analyzed for cell cycle distribution and sub-G<sub>1</sub> phase by using flow cytometry and CellQuest and Mod Fit computer programs (BD Biosciences Clontech, Palo Alto, CA, USA) as described previously [<xref ref-type="bibr" rid="B47-molecules-21-01353">47</xref>].</p>
      </sec>
      <sec id="sec4dot6-molecules-21-01353">
        <title>4.6. Measurements of Reactive Oxygen Species (ROS), Intracellular Ca<sup>2+</sup> and Mitochondrial Membrane Potential (&#x3A8;m)</title>
        <p>The levels of ROS, Ca<sup>2+</sup> and <italic>&#x3A8;m</italic> in NPC-TW 076 cells after being exposed to TET were measured by flow cytometric assay. NPC-TW 076 cells (1 &#xD7; 10<sup>5</sup> cells/well) in 12-well plates and/or cells were pretreated with NAC or 4PBA for 3 h followed by treated with TET (8 &#x3BC;M) for various time periods. Cells were isolated to re-suspend with 500 &#x3BC;L of DCFH-DA (10 &#x3BC;M), 500 &#x3BC;L of DiOC6 (4 &#x3BC;mol/L) and 500 &#x3BC;L of Fluo-3/AM (2.5 &#x3BC;g/mL) for measuring ROS, &#x394;&#x3A8;m and Ca<sup>2+</sup> levels, respectively or were assayed for total viable cells by using flow cytometry as described previously [<xref ref-type="bibr" rid="B48-molecules-21-01353">48</xref>]. </p>
      </sec>
      <sec id="sec4dot7-molecules-21-01353">
        <title>4.7. Western Blotting Analysis </title>
        <p>NPC-TW 076 cells (1 &#xD7; 10<sup>6</sup> cells/well) were seeded in 10 cm dishes for 24 h and then were treated with TET (8 &#x3BC;M) for 0, 6, 12, 24 and 48 h. Cells were collected and lysed in lysis buffer (100 mM Tris-Cl, pH 6.8, 4% (<italic>m</italic>/<italic>v</italic>) SDS, 20% (<italic>v</italic>/<italic>v</italic>) glycerol, 200 mM &#x3B2;-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, and 1 g/mL aprotinin). The total protein was measured by a protein assay kit (Bio-Rad, Hercules, CA, USA) as described previously. Then protein samples were separated with 12% (<italic>v</italic>/<italic>v</italic>) sodium dodeyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto the PVDF membranes (Millipore, Billerica, MA, USA). Immune complexes were formed by incubation of proteins with primary antibodies overnight at 4 &#xB0;C followed by a peroxidase-conjugated anti-mouse IgG (Cell Signaling Technology). Immunoreactive protein bands were detected using the enhanced chemiluminescence detection system (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA) [<xref ref-type="bibr" rid="B48-molecules-21-01353">48</xref>,<xref ref-type="bibr" rid="B49-molecules-21-01353">49</xref>]. Protein expression was quantified by densitometry using Image J.</p>
      </sec>
      <sec id="sec4dot8-molecules-21-01353">
        <title>4.8. Confocal Laser Scanning Microscopy Assay </title>
        <p>Confocal laser microscopy (Leica Inc., Heidelberg, Germany) was used to examine protein translocations as described previously. Briefly, NPC-TW 076 cells (5 &#xD7; 10<sup>4</sup> cells/well) in 4-well chamber slides were treated with TET (0 and 8 &#x3BC;M) for 24 h. And 4% formaldehyde in PBS was used to fix for 15 min followed by incubation with 0.3% Triton-X 100 in PBS for 1 h to make the cells permeable and then 2% BSA were used for blocking non-specific binding sites. Cells were incubated with primary antibodies such as anti-GADD153 and -GRP78 for overnight and cells were stained with secondary antibody (FITC-conjugated goat anti-mouse IgG) and PI (red fluorescence) staining for nuclear examinations. Slides were mounted, examined and photographed under a TCS SP2 Confocal Spectral Microscope (Leica Inc.) as described previously [<xref ref-type="bibr" rid="B50-molecules-21-01353">50</xref>].</p>
      </sec>
      <sec id="sec4dot9-molecules-21-01353">
        <title>4.9. Statistical Analysis</title>
        <p>Results were presented as mean &#xB1; standard deviation (SD) from triplicate experiments. Statistical analysis of all data was performed by Student&#x2019;s t test. All comparisons are made relative to untreated controls and significance of difference is indicated as * <italic>p</italic> &lt; 0.05, ** <italic>p</italic> &lt; 0.01, and *** <italic>p</italic> &lt; 0.001.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This work was supported by the grants CMU105-ASIA-03 from China Medical University, Taichung. Experiments and data analysis were performed in part through the use of the Medical Research Core Facilities Center, Office of Research &amp; Development at China medical University, Taichung, Taiwan.</p>
    </ack>
    <notes>
      <title>Author Contributions</title>
      <p>Y.-J.L., S.-F.P. and J.-G.C. contributed equally to the conception and design of the study; Y.-J.L. contributed equally to acquisition of data and analysis and interpretation of data; M.-L.L., C.-L.K., K.-W.L., C.-L.L., Y.-S.M., F.-S.C., and K.-C.L., drafting the article or revising it critically for important intellectual content; F.-S.Y., and J.-G.C. final approval of the version to be submitted. </p>
    </notes>
    <notes notes-type="COI-statement">
      <title>Conflicts of Interest</title>
      <p>The authors declare that there are no conflicts of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molecules-21-01353">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>E.T.</given-names>
            </name>
            <name>
              <surname>Adami</surname>
              <given-names>H.O.</given-names>
            </name>
          </person-group>
          <article-title>The enigmatic epidemiology of nasopharyngeal carcinoma</article-title>
          <source>Cancer Epidemiol. Biomark. Prev.</source>
          <year>2006</year>
          <volume>15</volume>
          <fpage>1765</fpage>
          <lpage>1777</lpage>
          <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-06-0353</pub-id>
          <pub-id pub-id-type="pmid">17035381</pub-id>
        </citation>
      </ref>
      <ref id="B2-molecules-21-01353">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cho</surname>
              <given-names>W.C.</given-names>
            </name>
          </person-group>
          <article-title>Nasopharyngeal carcinoma: Molecular biomarker discovery and progress</article-title>
          <source>Mol. Cancer</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>1</fpage>
          <pub-id pub-id-type="doi">10.1186/1476-4598-6-1</pub-id>
          <pub-id pub-id-type="pmid">17199893</pub-id>
        </citation>
      </ref>
      <ref id="B3-molecules-21-01353">
        <label>3.</label>
        <citation citation-type="gov">
          <source>The Cancer Mortality Report of the Department of Health</source>
          <publisher-name>Ministry of Health and Welfare</publisher-name>
          <publisher-loc>Taipei, Taiwan</publisher-loc>
          <year>2016</year>
        </citation>
      </ref>
      <ref id="B4-molecules-21-01353">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lo</surname>
              <given-names>K.W.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>D.P.</given-names>
            </name>
          </person-group>
          <article-title>Genetic and epigenetic changes in nasopharyngeal carcinoma</article-title>
          <source>Semin. Cancer Biol.</source>
          <year>2002</year>
          <volume>12</volume>
          <fpage>451</fpage>
          <lpage>462</lpage>
          <pub-id pub-id-type="doi">10.1016/S1044579X02000883</pub-id>
          <pub-id pub-id-type="pmid">12450731</pub-id>
        </citation>
      </ref>
      <ref id="B5-molecules-21-01353">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tao</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>A.T.</given-names>
            </name>
          </person-group>
          <article-title>Nasopharyngeal carcinoma: Molecular pathogenesis and therapeutic developments</article-title>
          <source>Expert Rev. Mol. Med.</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>1</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="doi">10.1017/S1462399407000312</pub-id>
          <pub-id pub-id-type="pmid">17477889</pub-id>
        </citation>
      </ref>
      <ref id="B6-molecules-21-01353">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>P.G.</given-names>
            </name>
          </person-group>
          <article-title>Epstein-Barr virus and oncogenesis: From latent genes to tumours</article-title>
          <source>Oncogene</source>
          <year>2003</year>
          <volume>22</volume>
          <fpage>5108</fpage>
          <lpage>5121</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1206556</pub-id>
          <pub-id pub-id-type="pmid">12910248</pub-id>
        </citation>
      </ref>
      <ref id="B7-molecules-21-01353">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Hui</surname>
              <given-names>E.P.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>A.T.</given-names>
            </name>
          </person-group>
          <article-title>Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: Current and future directions</article-title>
          <source>Cancer Sci.</source>
          <year>2008</year>
          <volume>99</volume>
          <fpage>1311</fpage>
          <lpage>1318</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1349-7006.2008.00836.x</pub-id>
          <pub-id pub-id-type="pmid">18498420</pub-id>
        </citation>
      </ref>
      <ref id="B8-molecules-21-01353">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruan</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>P.F.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M.Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J.L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy</article-title>
          <source>J. Cell. Biochem.</source>
          <year>2010</year>
          <volume>110</volume>
          <fpage>975</fpage>
          <lpage>981</lpage>
          <pub-id pub-id-type="doi">10.1002/jcb.22611</pub-id>
          <pub-id pub-id-type="pmid">20564197</pub-id>
        </citation>
      </ref>
      <ref id="B9-molecules-21-01353">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fulda</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Galluzzi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kroemer</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Targeting mitochondria for cancer therapy</article-title>
          <source>Nat. Rev. Drug Discov.</source>
          <year>2010</year>
          <volume>9</volume>
          <fpage>447</fpage>
          <lpage>464</lpage>
          <pub-id pub-id-type="doi">10.1038/nrd3137</pub-id>
          <pub-id pub-id-type="pmid">20467424</pub-id>
        </citation>
      </ref>
      <ref id="B10-molecules-21-01353">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>H.Z.</given-names>
            </name>
          </person-group>
          <article-title>Effects and mechanisms of emodin on cell death in human lung squamous cell carcinoma</article-title>
          <source>Br. J. Pharmacol.</source>
          <year>2001</year>
          <volume>134</volume>
          <fpage>11</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.bjp.0704205</pub-id>
          <pub-id pub-id-type="pmid">11522592</pub-id>
        </citation>
      </ref>
      <ref id="B11-molecules-21-01353">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boya</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Zamzami</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Vieira</surname>
              <given-names>H.L.</given-names>
            </name>
			<name>
              <surname>Kroemer</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Endoplasmic reticulum stress-induced cell death requires mitochondrial membrane permeabilization</article-title>
          <source>Cell. Death Differ.</source>
          <year>2002</year>
          <volume>9</volume>
          <fpage>465</fpage>
          <lpage>467</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.cdd.4401006</pub-id>
          <pub-id pub-id-type="pmid">11965500</pub-id>
        </citation>
      </ref>
      <ref id="B12-molecules-21-01353">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bradbury</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Simmons</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Slater</surname>
              <given-names>K.J.</given-names>
            </name>
			<name>
              <surname>Crouch</surname>
              <given-names>S.P.</given-names>
            </name>
          </person-group>
          <article-title>Measurement of the ADP:ATP ratio in human leukaemic cell lines can be used as an indicator of cell viability, necrosis and apoptosis</article-title>
          <source>J. Immunol. Methods</source>
          <year>2000</year>
          <volume>240</volume>
          <fpage>79</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-1759(00)00178-2</pub-id>
        </citation>
      </ref>
      <ref id="B13-molecules-21-01353">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ishitsuka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hideshima</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hamasaki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Raje</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Podar</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Le Gouill</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shiraishi</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Yasui</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Roccaro</surname>
              <given-names>A.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway</article-title>
          <source>Oncogene</source>
          <year>2005</year>
          <volume>24</volume>
          <fpage>5888</fpage>
          <lpage>5896</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1208739</pub-id>
          <pub-id pub-id-type="pmid">15940263</pub-id>
        </citation>
      </ref>
      <ref id="B14-molecules-21-01353">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ip</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>Y.L.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>P.Y.</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>H.C.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>H.Y.</given-names>
            </name>
            <name>
              <surname>Chueh</surname>
              <given-names>F.S.</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>T.Y.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>J.G.</given-names>
            </name>
          </person-group>
          <article-title>Bee venom induces apoptosis through intracellular Ca<sup>2+</sup> -modulated intrinsic death pathway in human bladder cancer cells</article-title>
          <source>Int. J. Urol.</source>
          <year>2012</year>
          <volume>19</volume>
          <fpage>61</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1442-2042.2011.02876.x</pub-id>
          <pub-id pub-id-type="pmid">22151644</pub-id>
        </citation>
      </ref>
      <ref id="B15-molecules-21-01353">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Lemos</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Iadecola</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Herbal alkaloid tetrandrine: Fron an ion channel blocker to inhibitor of tumor proliferation</article-title>
          <source>Trends Pharmacol. Sci.</source>
          <year>2004</year>
          <volume>25</volume>
          <fpage>120</fpage>
          <lpage>123</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tips.2004.01.009</pub-id>
          <pub-id pub-id-type="pmid">15058281</pub-id>
        </citation>
      </ref>
      <ref id="B16-molecules-21-01353">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Bao</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.P.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.T.</given-names>
            </name>
          </person-group>
          <article-title>Alkaloids isolated from natural herbs as the anticancer agents</article-title>
          <source>Evid. Based Complement. Altern. Med.</source>
          <year>2012</year>
          <volume>2012</volume>
          <fpage>485042</fpage>
          <pub-id pub-id-type="doi">10.1155/2012/485042</pub-id>
          <pub-id pub-id-type="pmid">22988474</pub-id>
        </citation>
      </ref>
      <ref id="B17-molecules-21-01353">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oh</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>B.H.</given-names>
            </name>
          </person-group>
          <article-title>Induction of apoptosis in human hepatoblastoma cells by tetrandrine via caspase-dependent Bid cleavage and cytochrome c release</article-title>
          <source>Biochem. Pharmacol.</source>
          <year>2003</year>
          <volume>66</volume>
          <fpage>725</fpage>
          <lpage>731</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-2952(03)00397-6</pub-id>
        </citation>
      </ref>
      <ref id="B18-molecules-21-01353">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuo</surname>
              <given-names>P.L.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>C.C.</given-names>
            </name>
          </person-group>
          <article-title>Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells</article-title>
          <source>Life Sci.</source>
          <year>2003</year>
          <volume>73</volume>
          <fpage>243</fpage>
          <lpage>252</lpage>
          <pub-id pub-id-type="doi">10.1016/S0024-3205(03)00266-2</pub-id>
        </citation>
      </ref>
      <ref id="B19-molecules-21-01353">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>V.W.</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase</article-title>
          <source>Oncol. Rep.</source>
          <year>2013</year>
          <volume>29</volume>
          <fpage>2205</fpage>
          <lpage>2210</lpage>
          <pub-id pub-id-type="pmid">23525490</pub-id>
        </citation>
      </ref>
      <ref id="B20-molecules-21-01353">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells</article-title>
          <source>J. Nat. Med.</source>
          <year>2014</year>
          <volume>68</volume>
          <fpage>46</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.1007/s11418-013-0765-0</pub-id>
          <pub-id pub-id-type="pmid">23564030</pub-id>
        </citation>
      </ref>
      <ref id="B21-molecules-21-01353">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cho</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Tehrani</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells</article-title>
          <source>J. Vet. Sci.</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>23</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="doi">10.4142/jvs.2009.10.1.23</pub-id>
          <pub-id pub-id-type="pmid">19255520</pub-id>
        </citation>
      </ref>
      <ref id="B22-molecules-21-01353">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>D.</given-names>
            </name>
			<name>
              <surname>He</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells</article-title>
          <source>J. Surg. Res.</source>
          <year>2011</year>
          <volume>166</volume>
          <fpage>e45</fpage>
          <lpage>e51</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jss.2010.10.034</pub-id>
          <pub-id pub-id-type="pmid">21176918</pub-id>
        </citation>
      </ref>
      <ref id="B23-molecules-21-01353">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>T.Y.</given-names>
            </name>
			<name>
              <surname>Tseng</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice</article-title>
          <source>Cancer Lett.</source>
          <year>2010</year>
          <volume>287</volume>
          <fpage>187</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="doi">10.1016/j.canlet.2009.06.009</pub-id>
          <pub-id pub-id-type="pmid">19586712</pub-id>
        </citation>
      </ref>
      <ref id="B24-molecules-21-01353">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>L.T.</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y.T.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>C.C.</given-names>
            </name>
          </person-group>
          <article-title>Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines</article-title>
          <source>Am. J. Chin. Med.</source>
          <year>2006</year>
          <volume>34</volume>
          <fpage>125</fpage>
          <lpage>135</lpage>
          <pub-id pub-id-type="doi">10.1142/S0192415X06003692</pub-id>
          <pub-id pub-id-type="pmid">16437745</pub-id>
        </citation>
      </ref>
      <ref id="B25-molecules-21-01353">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.Z.</given-names>
            </name>
			<name>
              <surname>Cheng</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1</article-title>
          <source>Oncol. Rep.</source>
          <year>2012</year>
          <volume>28</volume>
          <fpage>1681</fpage>
          <lpage>1686</lpage>
          <pub-id pub-id-type="pmid">22941407</pub-id>
        </citation>
      </ref>
      <ref id="B26-molecules-21-01353">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Lv</surname>
              <given-names>G.Y.</given-names>
            </name>
          </person-group>
          <article-title>Tetrandrine Suppresses Cancer Angiogenesis and Metastasis in 4T1 Tumor Bearing Mice</article-title>
          <source>Evid. Based Complement. Altern. Med.</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>265061</fpage>
          <pub-id pub-id-type="doi">10.1155/2013/265061</pub-id>
          <pub-id pub-id-type="pmid">23762115</pub-id>
        </citation>
      </ref>
      <ref id="B27-molecules-21-01353">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>W.</given-names>
            </name>
			<name>
              <surname>Kou</surname>
              <given-names>B.</given-names>
            </name>
			<name>
              <surname>Ma</surname>
              <given-names>Z.K.</given-names>
            </name>
			<name>
              <surname>Tang</surname>
              <given-names>X.S.</given-names>
            </name>
			<name>
              <surname>Lv</surname>
              <given-names>C.</given-names>
            </name>
			<name>
              <surname>Ye</surname>
              <given-names>M.</given-names>
            </name>
			<name>
              <surname>Chen</surname>
              <given-names>J.Q.</given-names>
            </name>
			<name>
              <surname>Li</surname>
              <given-names>L.</given-names>
            </name>
			<name>
              <surname>Wang</surname>
              <given-names>X.Y.</given-names>
            </name>
			<name>
              <surname>He</surname>
              <given-names>D.L.</given-names>
            </name>
          </person-group>
          <article-title>Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells</article-title>
          <source>Asian J. Androl.</source>
          <year>2015</year>
          <volume>17</volume>
          <fpage>850</fpage>
          <lpage>853</lpage>
          <pub-id pub-id-type="pmid">25677131</pub-id>
        </citation>
      </ref>
      <ref id="B28-molecules-21-01353">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Effects of Tetrandrine on Apoptosis and Radiosensitivity of Nasopharyngeal Carcinoma Cell Line CNE</article-title>
          <source>Acta Biochim. Biophys. Sin. (Shanghai)</source>
          <year>2007</year>
          <volume>39</volume>
          <fpage>869</fpage>
          <lpage>678</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1745-7270.2007.00349.x</pub-id>
          <pub-id pub-id-type="pmid">17989878</pub-id>
        </citation>
      </ref>
      <ref id="B29-molecules-21-01353">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>P.Y.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Guan</surname>
              <given-names>Z.Z.</given-names>
            </name>
          </person-group>
          <article-title>Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy</article-title>
          <source>Cancer Chemother. Pharmacol.</source>
          <year>2008</year>
          <volume>61</volume>
          <fpage>33</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="doi">10.1007/s00280-007-0441-8</pub-id>
          <pub-id pub-id-type="pmid">17909810</pub-id>
        </citation>
      </ref>
      <ref id="B30-molecules-21-01353">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Hui</surname>
              <given-names>E.P.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Tung</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Yuen</surname>
              <given-names>K.K.</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Kam</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>B.K.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma-correlation with excision repair cross-complementing-1 polymorphisms</article-title>
          <source>Ann. Oncol.</source>
          <year>2009</year>
          <volume>20</volume>
          <fpage>1854</fpage>
          <lpage>1859</lpage>
          <pub-id pub-id-type="doi">10.1093/annonc/mdp065</pub-id>
          <pub-id pub-id-type="pmid">19549713</pub-id>
        </citation>
      </ref>
      <ref id="B31-molecules-21-01353">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>T.W.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>C.Y.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>Y.C.</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>R.L.</given-names>
            </name>
          </person-group>
          <article-title>Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma</article-title>
          <source>Head Neck</source>
          <year>2006</year>
          <volume>28</volume>
          <fpage>74</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1002/hed.20310</pub-id>
          <pub-id pub-id-type="pmid">16331692</pub-id>
        </citation>
      </ref>
      <ref id="B32-molecules-21-01353">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy</article-title>
          <source>Oncotarget</source>
          <year>2016</year>
          <pub-id pub-id-type="doi">10.18632/oncotarget.8315</pub-id>
          <pub-id pub-id-type="pmid">27027348</pub-id>
        </citation>
      </ref>
      <ref id="B33-molecules-21-01353">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sarsour</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Chaudhuri</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kalen</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Goswami</surname>
              <given-names>P.C.</given-names>
            </name>
          </person-group>
          <article-title>Redox control of the cell cycle in health and disease</article-title>
          <source>Antioxid. Redox Signal.</source>
          <year>2009</year>
          <volume>11</volume>
          <fpage>2985</fpage>
          <lpage>3011</lpage>
          <pub-id pub-id-type="doi">10.1089/ars.2009.2513</pub-id>
          <pub-id pub-id-type="pmid">19505186</pub-id>
        </citation>
      </ref>
      <ref id="B34-molecules-21-01353">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sagara</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Maher</surname>
              <given-names>P.</given-names>
            </name>
			<name>
              <surname>Schubert</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>The regulation of reactive oxygen species production during programmed cell death</article-title>
          <source>J. Cell. Biol.</source>
          <year>1998</year>
          <volume>141</volume>
          <fpage>1423</fpage>
          <lpage>1432</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.141.6.1423</pub-id>
          <pub-id pub-id-type="pmid">9628898</pub-id>
        </citation>
      </ref>
      <ref id="B35-molecules-21-01353">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gulcin</surname>
              <given-names>I.O.</given-names>
            </name>
            <name>
              <surname>Beydemir</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kufrevioglu</surname>
              <given-names>O.I.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the antioxidant and antimicrobial activities of clary sage (<italic>Salvia sclarea</italic> L.)</article-title>
          <source>Turk. J. Agric. For.</source>
          <year>2004</year>
          <volume>28</volume>
          <fpage>9</fpage>
        </citation>
      </ref>
      <ref id="B36-molecules-21-01353">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Ip</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Endoplasmic reticulum stress signal mediators are targets of selenium action</article-title>
          <source>Cancer Res.</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>9073</fpage>
          <lpage>9079</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-2016</pub-id>
          <pub-id pub-id-type="pmid">16204082</pub-id>
        </citation>
      </ref>
      <ref id="B37-molecules-21-01353">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mori</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Tripartite management of unfolded proteins in the endoplasmic reticulum</article-title>
          <source>Cell</source>
          <year>2000</year>
          <volume>101</volume>
          <fpage>451</fpage>
          <lpage>454</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80855-7</pub-id>
        </citation>
      </ref>
      <ref id="B38-molecules-21-01353">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banerjee</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Czinn</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Blanchard</surname>
              <given-names>T.G.</given-names>
            </name>
          </person-group>
          <article-title>Endoplasmic reticulum stress and IRE-1 signaling cause apoptosis in colon cancer cells in response to andrographolide treatment</article-title>
          <source>Oncotarget</source>
          <year>2016</year>
          <pub-id pub-id-type="doi">10.18632/oncotarget.9180</pub-id>
          <pub-id pub-id-type="pmid">27166181</pub-id>
        </citation>
      </ref>
      <ref id="B39-molecules-21-01353">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kang</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Piao</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Hyun</surname>
              <given-names>J.W.</given-names>
            </name>
          </person-group>
          <article-title>Fisetin induces apoptosis in human nonsmall lung cancer cells via a mitochondria-mediated pathway</article-title>
          <source>In Vitro Cell. Dev. Biol. Anim.</source>
          <year>2015</year>
          <volume>51</volume>
          <fpage>300</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="doi">10.1007/s11626-014-9830-6</pub-id>
          <pub-id pub-id-type="pmid">25381036</pub-id>
        </citation>
      </ref>
      <ref id="B40-molecules-21-01353">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.A.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Chan-Salis</surname>
              <given-names>K.Y.</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>C.</given-names>
            </name>
			<name>
              <surname>Pugh</surname>
              <given-names>B.F.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3&#x2013;56 in Triple-Negative Breast Cancer Cells</article-title>
          <source>Mol. Cancer Ther.</source>
          <year>2015</year>
          <volume>14</volume>
          <fpage>877</fpage>
          <lpage>888</lpage>
          <pub-id pub-id-type="doi">10.1158/1535-7163.MCT-14-1093-T</pub-id>
          <pub-id pub-id-type="pmid">25612620</pub-id>
        </citation>
      </ref>
      <ref id="B41-molecules-21-01353">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ron</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Signal integration in the endoplasmic reticulum unfolded protein response</article-title>
          <source>Nat. Rev. Mol. Cell. Biol.</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>519</fpage>
          <lpage>529</lpage>
          <pub-id pub-id-type="doi">10.1038/nrm2199</pub-id>
          <pub-id pub-id-type="pmid">17565364</pub-id>
        </citation>
      </ref>
      <ref id="B42-molecules-21-01353">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hendershot</surname>
              <given-names>L.M.</given-names>
            </name>
          </person-group>
          <article-title>The ER function BiP is a master regulator of ER function</article-title>
          <source>Mt. Sinai J. Med.</source>
          <year>2004</year>
          <volume>71</volume>
          <fpage>289</fpage>
          <lpage>297</lpage>
          <pub-id pub-id-type="pmid">15543429</pub-id>
        </citation>
      </ref>
      <ref id="B43-molecules-21-01353">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hendershot</surname>
              <given-names>L.M.</given-names>
            </name>
          </person-group>
          <article-title>ER chaperone functions during normal and stress conditions</article-title>
          <source>J. Chem. Neuroanat.</source>
          <year>2004</year>
          <volume>28</volume>
          <fpage>51</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jchemneu.2003.08.007</pub-id>
          <pub-id pub-id-type="pmid">15363491</pub-id>
        </citation>
      </ref>
      <ref id="B44-molecules-21-01353">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>A novel derivative of tetrandrine (H1) induces endoplasmic reticulum stress-mediated apoptosis and prosurvival autophagy in human non-small cell lung cancer cells</article-title>
          <source>Tumour Biol.</source>
          <year>2016</year>
          <volume>37</volume>
          <fpage>10403</fpage>
          <lpage>10413</lpage>
          <pub-id pub-id-type="doi">10.1007/s13277-016-4950-0</pub-id>
          <pub-id pub-id-type="pmid">26846103</pub-id>
        </citation>
      </ref>
      <ref id="B45-molecules-21-01353">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oyadomari</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Roles of CHOP/GADD153 in endoplasmic reticulum stress</article-title>
          <source>Cell. Death Differ.</source>
          <year>2004</year>
          <volume>11</volume>
          <fpage>381</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.cdd.4401373</pub-id>
          <pub-id pub-id-type="pmid">14685163</pub-id>
        </citation>
      </ref>
      <ref id="B46-molecules-21-01353">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>M.-C.</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>S.-Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>F.-Y.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>F.-H.</given-names>
            </name>
            <name>
              <surname>Syu</surname>
              <given-names>J.-N.</given-names>
            </name>
			<name>
              <surname>Tang</surname>
              <given-names>F.-Y.</given-names>
            </name>
          </person-group>
          <article-title>Leptin induces cell invasion and the upregulation of matrilysin in human colon cancer cells</article-title>
          <source>Biomedicine</source>
          <year>2013</year>
          <volume>3</volume>
          <fpage>174</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biomed.2013.09.001</pub-id>
        </citation>
      </ref>
      <ref id="B47-molecules-21-01353">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>CHM-1 Suppresses Formation of Cell Surface-associated GRP78-p85alpha Complexes, Inhibiting PI3K-AKT Signaling and Inducing Apoptosis of Human Nasopharyngeal Carcinoma Cells</article-title>
          <source>Anticancer Res.</source>
          <year>2015</year>
          <volume>35</volume>
          <fpage>5359</fpage>
          <lpage>5368</lpage>
          <pub-id pub-id-type="pmid">26408697</pub-id>
        </citation>
      </ref>
      <ref id="B48-molecules-21-01353">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>F.S.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Chiu</surname>
              <given-names>C.F.</given-names>
            </name>
			<name>
              <surname>Chung</surname>
              <given-names>J.G.</given-names>
            </name>
          </person-group>
          <article-title>Safrole induces cell death in human tongue squamous cancer SCC-4 cells through mitochondria-dependent caspase activation cascade apoptotic signaling pathways</article-title>
          <source>Environ. Toxicol.</source>
          <year>2012</year>
          <volume>27</volume>
          <fpage>433</fpage>
          <lpage>444</lpage>
          <pub-id pub-id-type="doi">10.1002/tox.20658</pub-id>
          <pub-id pub-id-type="pmid">21591240</pub-id>
        </citation>
      </ref>
      <ref id="B49-molecules-21-01353">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>T.-Y.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>C.-W.</given-names>
            </name>
            <name>
              <surname>Maa</surname>
              <given-names>M.-C.</given-names>
            </name>
			<name>
              <surname>Leu</surname>
              <given-names>T.-H.</given-names>
            </name>
          </person-group>
          <article-title>Lipopolysaccharide-promoted proliferation of Caco-2 cells is mediated by c-Src induction and ERK activation</article-title>
          <source>Biomedicine</source>
          <year>2015</year>
          <volume>5</volume>
          <fpage>1</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.7603/s40681-015-0005-x</pub-id>
          <pub-id pub-id-type="pmid">25705585</pub-id>
        </citation>
      </ref>
      <ref id="B50-molecules-21-01353">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsia</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>N.Y.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>H.F.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>J.G.</given-names>
            </name>
			<name>
              <surname>Chung</surname>
              <given-names>J.G.</given-names>
            </name>
          </person-group>
          <article-title>Cantharidin induces DNA damage and inhibits DNA repair-associated protein levels in NCI-H460 human lung cancer cells</article-title>
          <source>Environ. Toxicol.</source>
          <year>2015</year>
          <volume>30</volume>
          <fpage>1135</fpage>
          <lpage>1143</lpage>
          <pub-id pub-id-type="doi">10.1002/tox.21986</pub-id>
          <pub-id pub-id-type="pmid">24639390</pub-id>
        </citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p><bold>Sample Availability:</bold> Samples of the compounds are not available from the authors.</p>
      </fn>
    </fn-group>
    <sec sec-type="display-objects">
      <title>Figures</title>
      <fig id="molecules-21-01353-f001" position="float">
        <label>Figure 1</label>
        <caption>
          <p>TET decreases the number of viable NPC-TW 076 cells and induced cell morphological changes in vitro. Cells were treated with TET at a concentration range of 0&#x2013;10 &#x3BC;M for 48 h and then the cells were collected for the percentage of viable cell measurements (<bold>A</bold>) by flow cytometry as described in Materials and Methods. IC<sub>50</sub> is examined to be 8.2 &#x3BC;M (<bold>B</bold>). Cells were examined and photographed for cell morphological changes by contrast-phase microscopy at 200&#xD7; (<bold>C</bold>) or * <italic>p</italic> &lt; 0.05, significant difference between TET-treated groups and the control as analyzed by Student&#x2019;s t test.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g001.tif"/>
      </fig>
      <fig id="molecules-21-01353-f002" position="float">
        <label>Figure 2</label>
        <caption>
          <p>TET induces nuclear chromatin condensation in NPC-TW 076 cells. Cells were treated with 0, 4, 6, 8 and 10 &#x3BC;M of TET for 48 h and then were stained with DAPI as described in Materials and Methods. Cells were examined and photographed using a fluorescence microscope at 200&#xD7; (<bold>A</bold>) and the DAPI fluorescence intensity were quantified (<bold>B</bold>). * <italic>p</italic> &lt; 0.05, significant difference between TET-treated groups and the control as analyzed by Student&#x2019;s t test.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g002.tif"/>
      </fig>
      <fig id="molecules-21-01353-f003" position="float">
        <label>Figure 3</label>
        <caption>
          <p>TET induces G<sub>0</sub>/G<sub>1</sub> phase arrest and sub-G<sub>1</sub> phase in NPC-TW 076 cells. Cells (1 &#xD7; 10<sup>5</sup> cells/well) in 12-well plates and were incubated with TET (0&#x2013;10 &#x3BC;M) for 48 h. Cells were harvested and fixed in 70% ethanol and then incubated with a solution containing 50 mg/mL PI and 50 &#x3BC;g/mL RNase A for 30 min in the dark at 37 &#xB0;C. Cells were analyzed for cell cycle distribution (<bold>A</bold>) by flow cytometer or were evaluated for the percentage of cell cycle distribution (<bold>B</bold>) as described in Materials and Methods.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g003a.tif"/>
		<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g003b.tif"/>
      </fig>
      <fig id="molecules-21-01353-f004" position="float">
        <label>Figure 4</label>
        <caption>
          <p>TET induces reactive oxygen species (ROS) and Ca<sup>2+</sup> production and affects the levels of mitochondrial membrane potential (<italic>&#x394;&#x3A8;m</italic>) in NPC-TW 076 cells. Cells (1 &#xD7; 10<sup>5</sup> cells/well) were treated with TET (8 &#x3BC;M) for various time periods. Cells were isolated and then were re-suspended in DCFH-DA for ROS (H<sub>2</sub>O<sub>2</sub>) (<bold>A</bold>) and cells were pretreated with NAC and then were measured for ROS (<bold>B</bold>) and the number of viable cells (<bold>C</bold>), re-suspended in Fluo-3/AM for further intracellular Ca<sup>2+</sup> concentrations (<bold>D</bold>) and cells were pretreated with NAC (<bold>E</bold>) or 4PBA (<bold>F</bold>) and then were measured for Ca<sup>2+</sup> production, and re-suspended in DiOC<sub>6</sub> for the levels of <italic>&#x3A8;m</italic> measurement (<bold>G</bold>) as described in Materials and Methods. The results are shown as a mean &#xB1; SD (<italic>n</italic> = 3); * <italic>p</italic> &lt; 0.05 or *** <italic>p</italic> &lt; 0.001 significant difference between TET-treated groups and the control as analyzed by Student&#x2019;s t test.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g004a.tif"/>
		<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g004b.tif"/>
		<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g004c.tif"/>
      </fig>
      <fig id="molecules-21-01353-f005" position="float">
        <label>Figure 5</label>
        <caption>
          <p>TET affects apoptosis associated protein expression in NPC-TW 076 cells. Cells were treated with 8 &#x3BC;M of TET for 0, 6, 12, 24 and 48 h and then total proteins were quantitated and apoptosis associated proteins were measured by western blotting as described in Materials and Methods. (<bold>A</bold>): FasL, Fas, caspase-8 and -7; (<bold>B</bold>): Bcl-xL, Bcl-2, Bid and Bax; (<bold>C</bold>): Cyto C, AIF, Endo G and XIAP; (<bold>D</bold>): Calpain 1 and 2, caspase-12, IRE-1&#x3B1; and IRE-1&#x3B2;; (<bold>E</bold>): GADD153, GRP78, ATF-6&#x3B1; and ATF-6&#x3B2;; (<bold>F</bold>): GRP78, caspase-12, ATF-6&#x3B1; and ATF-6&#x3B2;; (<bold>G</bold>): Catalase, GST, SOD (Cu/Zn) and SOD (Mn); (<bold>H</bold>): CHOP, eIF2&#x3B1;, PARP, and caspase-3.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g005a.tif"/>
		<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g005b.tif"/>
      </fig>
      <fig id="molecules-21-01353-f006" position="float">
        <label>Figure 6</label>
        <caption>
          <p>TET affects the translocation of apoptotic associated proteins in NPC-TW 076 cells. Cells were treated with 8 &#x3BC;M of TET for 24 h and cells were stained by anti- GADD153 (<bold>A</bold>) and GRP78 (<bold>B</bold>) and were stained with secondary antibody (FITC-conjugated goat anti-mouse IgG (green fluorescence) and PI (nuclear staining; red fluorescence) and followed by being examined and photographed by a Leica TCS SP2 confocal laser microscopic systems as described in Materials and Methods.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g006a.tif"/>
		<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g006b.tif"/>
      </fig>
      <fig id="molecules-21-01353-f007" position="float">
        <label>Figure 7</label>
        <caption>
          <p>The possible signaling pathways for tetrandrine-induced apoptosis in NPC-TW 076 human nasopharyngeal carcinoma cells.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-21-01353-g007.tif"/>
      </fig>
    </sec>
  </back>
</article>
